Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways. (2023)

First Author: Spain L
Attributed to:  Enhancing immunogenicity in non-viral low mutation burden tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-22-1427

PubMed Identifier: 36977461

Publication URI: http://europepmc.org/abstract/MED/36977461

Type: Journal Article/Review

Volume: 13

Parent Publication: Cancer discovery

Issue: 6

ISSN: 2159-8274